Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F2ML
|
|||
| Former ID |
DNC004594
|
|||
| Drug Name |
MEDETOMIDINE
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H16N2
|
|||
| Canonical SMILES |
CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
|
|||
| InChI |
1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)
|
|||
| InChIKey |
CUHVIMMYOGQXCV-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 86347-14-0
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:48552
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Sedative and cardiopulmonary effects of medetomidine hydrochloride and xylazine hydrochloride and their reversal with atipamezole hydrochloride in calves. Am J Vet Res. 2008 Mar;69(3):319-29. | |||
| REF 2 | A structure-activity relationship study of benzylic modifications of 4-[1-(1-naphthyl)ethyl]-1H-imidazoles on alpha 1- and alpha 2-adrenergic recep... J Med Chem. 1994 Jul 22;37(15):2328-33. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.